首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1297766

全球美容外科市場 - 2023-2030

Global Cosmetic Surgery Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球美容手術市場在2022年達到613億美元，預計到2030年將見證有利可圖的成長，達到1322億美元。在預測期間（2023-2030年），全球美容整形市場預計將呈現10.4%的複合成長率。進行美容整形手術是為了改變外觀。對一些人來說，這意味著重塑身體的輪廓和形態，撫平皺紋，或去除禿頭。其他人則選擇靜脈曲張治療或隆胸。

美容手術的主要目的是為了提高外觀。美容手術的治療方法、技術和理念完全集中在改善外觀上。主要目的是改善視覺吸引力、對稱性和比例。美容手術可以在頭部、頸部或身體的任何部位進行。美容手術被認為是選擇性的，因為它們解決的是功能正常的區域。

市場動態

女性美容手術患者的增加

根據國際美容整形外科協會（ISAPS）的數據，女性美容手術患者的增加可歸因於女性對身體外觀的關注和新興經濟體人均消費的增加。提供各種服務並擁有尖端技術和項目的醫療水療中心數量不斷增加，進一步支持了這個因素。這些因素促進了市場中女性部分的成長。

對微創外科手術的需求上升

整容手術的主要好處之一是效果通常是持久的或永久的，因為對整容手術的需求增加，它已被更自由地提供，並已建立了許多診所。

整容手術的這些重要優勢導致了市場的擴大。可支配收入的擴大，更多的社會意識，娛樂業對這些治療的需求擴大，以及需要整形改造的災難性事故頻率的上升，都是市場的驅動力。

美容手術的高成本

在許多新興和中等收入國家，美容手術已經變得"不那麼容易獲得"。這似乎是阻礙市場擴張的主要問題。恢復期往往長達2-3週，阻礙了市場的發展。

此外，印度的整形手術費用在15,000印度盧比（188美元）到2,50000印度盧比（3,133美元）之間，甚至更高，這取決於所選擇的技術、手術中遇到的困難、醫院提供的額外服務、諮詢和測試。這種令人望而卻步的治療價格可能會扼殺市場的擴張。

COVID-19影響分析

由於封鎖預防措施和對選擇性手術的限制，許多美容外科診所和機構在疫情初期不得不暫時停止或減少服務。因此，進行美容治療的數量大大減少。對感染病毒的恐懼，財務上的不確定性，以及對基本醫療服務的關注，都導致了對美容手術需求的下降。

許多人推遲或取消了選擇性手術，以便在整個流行病期間優先考慮他們的健康和安全。例如，2020年的美容整形手術治療量下降了10.9%，全世界有77.8%的臨床醫生因COVID-19疫情而臨時關閉診所。非手術程序（主要是填充物和脫毛治療）成長，儘管速度比前幾年慢。因此，總體手術量下降了1.8%。

Market Overview

The Global Cosmetic Surgery Market reached US$ 61.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 132.2 billion by 2030. The global cosmetic surgery market is expected to exhibit a CAGR of 10.4% during the forecast period (2023-2030). Cosmetic plastic surgery is performed to alter look. For some, it implies reshaping the body's contour and form, smoothing wrinkles, or removing bald spots. Others choose for varicose vein therapy or breast augmentation.

Cosmetic surgery primary principal is focused to enhance the appearance. Cosmetic surgery treatments, techniques, and philosophies are solely focused on improving look. The primary aims are to improve visual appeal, symmetry, and proportion. Aesthetic surgery can be done on any part of the head, neck, or body. Cosmetic operations are considered elective since they address regions that function normally.

Market Dynamics

Rise in Female Cosmetic Surgery Patients

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the increase in female cosmetic surgery patients can be ascribed to females' increased attention on physical appearance and rising per capita spending in emerging economies. This factor is bolstered further by the expanding number of medical spas that provide a variety of services and boast cutting-edge technology and items. These factors contribute to the market's female segment's growth.

Rise In the Demand for Minimally Invasive Surgical Procedures

One of the primary benefits of cosmetic surgery is that the effects are generally long-lasting or permanent because of the increased demand for cosmetic operations, it has been more freely available, and numerous clinics have been established.

These important advantages for cosmetic surgery led to market expansion. Expanding disposable income, more societal awareness, expanding demand for these treatments in the entertainment business, and a rise in the frequency of catastrophic accidents needing reconstructive alterations are all driving drivers for the market.

High Cost of Cosmetic Surgeries

Cosmetic surgery has become 'not so simply accessible' in many emerging and middle-income nations. This appears to be the primary issue impeding market expansion. Recovery period can often be as lengthy as 2-3 weeks, preventing the market from increasing.

Also, plastic surgery in India costs between INR 15,000 ($188) and INR 2,50,000 ($3,133), or even more, depending on the technique chosen, difficulties encountered during the operation, additional services provided by the hospital, consultations, and tests. This prohibitive price of therapy may stifle market expansion.

COVID-19 Impact Analysis

Many cosmetic surgery clinics and organizations had to temporarily stop or reduce their services during the early phases of the epidemic owing to lockdown precautions and limits on elective procedures. As a result, the number of cosmetic treatments performed has decreased significantly. Fear of getting the virus, financial uncertainty, and a focus on basic healthcare services all contributed to a drop in demand for aesthetic operations.

Many people postponed or cancelled elective operations in order to priorities their health and safety throughout the epidemic. The amount of aesthetic plastic surgery treatments, for instance, fell by 10.9% in 2020, with 77.8% of clinicians worldwide experiencing temporary practise closures owing to the COVID-19 epidemic. Nonsurgical procedures (mostly fillers and hair removal treatments) grew, albeit at a slower rate than in previous years. As a result of this, overall operations decreased by 1.8%.

Segment Analysis

The global cosmetic surgery market is segmented based on procedure and product and region.

The Breast augmentation Surgical Procedure Segment Will Account for Approximately 36.7% During the Forecast Period

Breast augmentation remains the most common surgical procedure for women, while surgery to remove implants increased by 22.6 percent, and breast lifts increased by 31.4% in the last year, according to the ISAPS survey. For instance, The International Society of Aesthetic Plastic Surgery (ISAPS) presented the findings of its annual Global Survey on Aesthetic/Cosmetic treatments, which revealed a 19.3% rise in cosmetic surgery treatments.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America has the largest share accounting for 40.7% during the forecast period. The size of the market in the area is predicted to grow steadily in the future years. The increased acceptance of cosmetic surgery and widespread knowledge are important driving elements behind the market's expansion. Furthermore, fast improvements in associated technologies like as improved silicone and polymer implants are propelling the region's cosmetic surgery business.

Competitive Landscape

The major global players include: AbbVie, Bausch Health Companies, Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH, Sientra, Sinclair Pharma, and Teoxane Laboratories.

Why Purchase the Report?

To visualize the global cosmetic surgery market segmentation based on the procedures and product and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global cosmetic surgery market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global cosmetic surgery market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1 Snippet by Procedures
3.2 Snippet by Product
3.4 Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1 Rise in Female Cosmetic Surgery Patients
  - 4.1.1.2 Rise in the demand for minimally invasive surgical procedures
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Cosmetic Surgeries
- 4.1.3. Opportunity
  - 4.1.3.1The introduction of self-monitoring apps
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Procedure

7.1. Abdominoplasty
7.2. Blepharoplasty
7.3. Mammoplasty
7.4. Buttock augmentation
7.5. Laser Skin Rejuvenation
7.6. Face Surgery
7.7. Liposuction
7.8. Other

8. By Product

8.1. Implants
- 8.1.1. Lip Implants
- 8.1.2. Breast Implants
- 8.1.3. Buttock Implants
- 8.1.4. Chin and Cheek Implants
8.2. Equipment
- 8.2.1. Hair removal lasers
- 8.2.2. Dermal resurfacing lasers
- 8.2.3. Liposuction equipment
- 8.2.4. Microdermabrators
8.3. Injectables
- 8.3.1. Botulinum toxin
- 8.3.2. Collagen
- 8.3.3. Hyaluronic acid

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. AbbVie
- 11.1.1. Company overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Bausch Health Companies
11.3. Candela Syneron
11.4. Cynosure Technologies
11.5. Galderma SA
11.6. Johnson and Johnson
11.7. Merz Pharma GmbH
11.8. Sientra
11.9. Sinclair Pharma
11.10. Teoxane Laboratories

LIST NOT EXHAUSTIVE